摘要
目的 研究造血干细胞移植期(HSCT)细胞因子及受体水平的变化、免疫重建与急性移植物抗宿主病(aGVHD)的关系,以探讨临床预测aGVHD的指标。方法 22例HSCT患者,采用双夹心ELISA动态监测血清细胞因子及受体白细胞介素-6、白细胞介素-8、干扰素-γ、肿瘤坏死因子-a、可溶性白细胞介素-2受体(sIL-2R)水平的变化、流式细胞仪检测移植后淋巴细胞亚群CD3+、CD4+、CD8+、CD25+、CD69+细胞的重建。结果 22例患者均获得造血重建,6例发生I度GVHD,4例发生Ⅲ-Ⅳ度GHVD。sIL-2R在aGVHD发生组于移植后第2周上升,第3周达峰值,Ⅲ-Ⅳ度GVHD峰值为(420.3±59.8)U/L,I度GVHD峰值为(221.5±38.8)U/L,早于aGVHD的症状出现,与疾病的严重程度显著相关,随症状的缓解而下降。其他细胞因子水平的变化与aGVHD的发生无明显关系。CD25+细胞的升高与sIL-2R一致。结论分析移植后患者血清细胞因子水平的变化及免疫重建可以预测aGVHD的发生,sIL-2R、CD25+细胞在aGVHD发生之前明显上升,是预测aGVHD的指标。
Objective: Acute graft-versus-host disease (aGVHD) is one of the major complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT).Prediction of human aGVHD may be of help in its diagnosis and therapy. Methods 22 patients undergoing HSCT were included in this study. After transplantation, serum concentrations of interlukin-6. interlukin-8. tumor necrosis factor-a, interforon-γ and sIL-2R were measured periordically by using enzymed-linked immunosorbent assay. Immune reconstitution of CD3+ .CD4+ .CD8+ .CD25+ and CD69+ cells were analyzed with flow cytometry. Results All the patients achieved engraftment. 6 patients developed grade I GVHD and 4 patients deveolped grade Ⅲ-Ⅳ GAHD. Patients with aGVHD demonstrated significantly higher sIL-2R levels than those without. The peak levels of grade Ⅲ-Ⅳ GVHD were(420.3 ± 59.8) U/L,and the peak levels of grade I GVHD were (221.5 ± 38.8)U/L. The increase of sIL-2R level in serum preceded the clinical signs of aGVHD .The maximum levels of sIL-2R correlated significantly with the seventy of aGVHD.The increase of CD25+ cells was in acordance with that of sIL-2R. Conclusions Analysis of serum cytokines and immune reconstitution after HSCT may provide predictive value for aGVHD.
出处
《中华内科杂志》
CAS
CSCD
北大核心
2001年第4期222-225,共4页
Chinese Journal of Internal Medicine
基金
国家自然科学基金资助项目(39870710)
上海市卫生系统"百人计划"资助项目(98BR029)